参考文献
(在框内滑动手指即可浏览)
[1] 薛刚,李凌帆,杨勇,等. 分化型甲状腺癌二次手术原因分析及应对策略[J]. 中华内分泌外科杂志,2018,12(5):439-440.
[2] Farahati J, Mader U, Gilman E, et al. Changing trends of incidence and prognosis of thyroid carcinoma[J]. Nuklearmedizin,2019,58(2):86-92.
[3] Elisei R, Viola D, Torregrossa L, et al. The BRAF(V600E) mutation is an independent, poor prognostic factor for the outcome of patients with low-risk intrathyroid papillary thyroid carcinoma: single-institution results from a large cohort study[J]. J Clin Endocrinol Metab,2012,97(12):4390-4398.
[4] Pedrazzini L, Baroli A, Marzoli L, et al. Cancer recurrence in papillary thyroid microcarcinoma: a multivariate analysis on 231 patients with a 12-year follow-up[J]. Minerva Endocrinol,2013,38(3):269-279.
[5] Ross DS, Litofsky D, Ain KB, et al. Recurrence after treatment of micropapillary thyroid cancer[J]. Thyroid,2009,19(10):1043-1048.
[6] Pellegriti G, Scollo C, Lumera G, et al. Clinical behavior and outcome of papillary thyroid cancers smaller than 1.5 cm in diameter: study of 299 cases[J]. J Clin Endocrinol Metab,2004,89(8):3713-3720.
[7] Crepeau PK, Kulkarni K, Martucci J, et al. Comparing surgical thoroughness and recurrence in thyroid cancer patients across race/ethnicity[J]. Surgery,2021.Doi:10.1016/j.surg.2021.05.001.
[Online ahead of print].
[8] Hollenbeak CS, Boltz MM, Schaefer EW, et al. Recurrence of differentiated thyroid cancer in the elderly[J]. Eur J Endocrinol,2013,168(4):549-556.
[9] Luo X, Wu A. Analysis of risk factors for postoperative recurrence of thyroid cancer[J]. J BUON,2019,24(2):813-818.
[10] 中华医学会内分泌学分会, 中华医学会外科学分会 ,中国抗癌协会头颈肿瘤专业委员会,等.甲状腺结节和分化型甲状腺癌诊治指南[J]. 中国肿瘤临床,2012,39(17):1249-1272.
[11] 田文,姚京. 重视甲状腺结节规范化诊治[J]. 中国实用外科杂志,2015,35(6):579-583.
[12] Lamartina L, Borget I, Mirghani H, et al. Surgery for neck recurrence of differentiated thyroid cancer: Outcomes and risk factors[J]. J Clin Endocrinol Metab,2017,102(3):1020-1031.
[13] 张浩. Ⅵ区淋巴结清扫术中甲状旁腺保护和损伤处理[J]. 中国实用外科杂志,2012,32(5):361-363.
[14] 杨连粤,黄耿文. 甲状腺癌的再次手术治疗[J]. 中国实用外科杂志,2004,24(10):19-20.
[15] 李智勇,衣荟洁,李正天,等. 甲状腺二次手术喉返神经损伤的危险因素分析[J]. 国际外科学杂志,2020,47(8):555-559.
[16] 黄天立,巴明臣,林宗伟,等. 甲状腺再手术入路方式探讨[J]. 中国实用外科杂志,2001,21(3):37.
[17] 朱一鸣,刘绍严. 再谈甲状腺手术喉返神经损伤的相关因素[J]. 中国实用外科杂志,2018,38(6):607-612.
[18] Bai B, Chen W. Protective Effects of Intraoperative Nerve Monitoring (IONM) for Recurrent Laryngeal Nerve Injury in Thyroidectomy: Meta-analysis[J]. Sci Rep,2018,8(1):7761.
[19] 邵堂雷,王振乾,蒋晓,等. 甲状腺再次手术中喉返神经保护研究(附163例分析)[J]. 中国实用外科杂志,2015,35(6):656-658.
[20] 张晓,刘超,马贵亮,等. 喉返神经监测在甲状腺再次手术中临床价值的meta分析[J]. 临床普外科电子杂志,2018,6(2):26-34.
[21] 吴文澜,姚卫萍,蒋媛,等. 基于倾向性评分评价喉返神经监测在甲状腺癌再手术中的应用方法和价值[J]. 肿瘤学杂志,2020,26(6):556-559.
[22] 中国医师协会外科医师分会甲状腺外科医师委员会,中华医学会外科学分会甲状腺及代谢外科学组,中国研究型医院学会甲状腺疾病专业委员会. 甲状腺围手术期甲状旁腺功能保护指南(2018版)[J]. 中国实用外科杂志,2018,38(10):1108-1113.
[23] 吴华锦,盛宇,崔君鹏,等. 纳米炭在甲状腺癌手术治疗中作用的Meta分析[J]. 国际外科学杂志,2020,47(8):534-539.
[24] 孙玮笛,杨洁,任艳鑫,等. 免疫胶体金试纸法验证甲状旁腺的临床应用研究[J]. 中国肿瘤临床,2019,46(23):1206-1211.
[25] 韦树建,郑桂彬,刘洋,等. 甲状旁腺自体荧光在甲状腺癌根治手术中的临床应用[J]. 中国耳鼻咽喉头颈外科,2020,27(8):446-450.
[26] 田文,陈志达,郗洪庆,等. 近红外自体荧光显像技术在甲状腺癌根治性手术中辅助甲状旁腺识别应用1例报告并文献复习[J]. 中国实用外科杂志,2020,40(5):591-593.